Marketing Pharma
Menu
GENVOYA - ELVITEGRAVIR 150mg/COBICISTAT 150mg/EMTRICITABINE 200mg/TENOFOVIR ALAFENAMIDE10mg

GENVOYA - ELVITEGRAVIR 150mg/COBICISTAT 150mg/EMTRICITABINE 200mg/TENOFOVIR ALAFENAMIDE10mg

Ask on WhatsApp
  • Where we areCL 86A BIS 15 22, CHAPINERO, BOGOTÁ
  • Advice on WhatsAppMessage us at +573172701347

Description

Invima: 2019M-0018958

Genvoya is indicated for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection without any known mutation associated with resistance to integrase inhibitors, emtricitabine or tenofovir:

In adults and adolescents aged 12 years and older with a body weight of at least 35kg. In children aged 6 years and older with a body weight of at least 25kg for whom other alternative treatments are not suitable due to toxicities.

Not applicable to people with ADHD, high levels of hypertension, or kidney, liver, heart, bronchial, endocrine or genetic health problems, or that are available in their country.

 

You may also like